Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion type Assertion NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_head.
- NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion description "[These results directly demonstrate that BCR-ABL(+) stem cells persist in CML patients despite prolonged treatment with imatinib, and support ongoing efforts to target this population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_provenance.
- NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion evidence source_evidence_literature NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_provenance.
- NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion SIO_000772 21931114 NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_provenance.
- NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion wasDerivedFrom befree-2016 NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_provenance.
- NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_assertion wasGeneratedBy ECO_0000203 NP924855.RAb-MmlBQZs9vNqDZRPV7158rM0_t3pt00vlTS8ny82EI130_provenance.